Treatment outcomes of hips in patients with epiphyseal dysplasia.


Journal

Journal of pediatric orthopedics. Part B
ISSN: 1473-5865
Titre abrégé: J Pediatr Orthop B
Pays: United States
ID NLM: 9300904

Informations de publication

Date de publication:
01 Nov 2022
Historique:
pubmed: 4 5 2022
medline: 5 10 2022
entrez: 3 5 2022
Statut: ppublish

Résumé

Hip containment surgeries in multiple epiphyseal and spondyloepiphyseal dysplasia (MED/SED) patients aim to improve the mechanical environment of the hip joint. The purpose of this study was to determine if surgical intervention to improve femoral head coverage improved radiographic and clinical outcomes. A retrospective study identified patients with MED/SED seen in clinic between May 2000 and September 2017, with a minimum of 2-year follow-up. Patient charts/radiographs were reviewed for radiographic hip measurements, pain, and gait. Sixty-nine hips in 35 patients were identified. Forty-four hips were treated nonoperatively and 25 were treated surgically. The mean age at diagnosis was 6.2 years. The mean follow-up was 7.7 years for the surgical group and 7.1 years for the nonsurgical group. The mean postoperative follow-up was 5.4 years. Acetabular index decreased from initial to final visit by 9.0° in the surgical group and 1.6° in the nonsurgical group. Tonnis angle decreased by 13.5° in the surgical group and 1.5° in the nonsurgical group. Center edge angle increased by 19.0° in the surgical group and 7.1° in the nonsurgical group. Hips in the surgical group were 6.1 times more likely to experience an improvement in pain compared with hips in the nonsurgical group. Gait at the final follow-up was similar among the two groups. In this study cohort, containment surgery provided increased femoral head coverage; however, there was equal femoral head deformation despite intervention. Hips treated surgically were more likely to experience an improvement in pain; however, gait alterations did not improve.

Identifiants

pubmed: 35502749
doi: 10.1097/BPB.0000000000000982
pii: 01202412-202211000-00006
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

554-559

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Références

Anthony S, Munk R, Skakun W, Masini M. Multiple epiphyseal dysplasia. J Am Acad Orthop Surg. 2015; 23:164–172.
Unger S, Bonafé L, Superti-Furga A. Multiple epiphyseal dysplasia: clinical and radiographic features, differential diagnosis and molecular basis. Best Pract Res Clin Rheumatol. 2008; 22:19–32.
Bajuifer S, Letts M. Multiple epiphyseal dysplasia in children: beware of overtreatment! Can J Surg. 2005; 48:106–109.
Panda A, Gamanagatti S, Jana M, Gupta AK. Skeletal dysplasias: a radiographic approach and review of common non-lethal skeletal dysplasias. World J Radiol. 2014; 6:808–825.
Deng H, Huang X, Yuan L. Molecular genetics of the COL2A1-related disorders. Mutat Res Rev Mutat Res. 2016; 768:1–13.
Terhal PA, Nievelstein RJ, Verver EJ, Topsakal V, van Dommelen P, Hoornaert K, et al. A study of the clinical and radiological features in a cohort of 93 patients with a COL2A1 mutation causing spondyloepiphyseal dysplasia congenita or a related phenotype. Am J Med Genet A. 2015; 167A:461–475.
Damignani R, Young NL, Cole WG, Anthony AM, Badley EM. Impairment and activity limitation associated with epiphyseal dysplasia in children. Arch Phys Med Rehabil. 2004; 85:1647–1652.
Briggs MD, Chapman KL. Pseudoachondroplasia and multiple epiphyseal dysplasia: mutation review, molecular interactions, and genotype to phenotype correlations. Hum Mutat. 2002; 19:465–478.
Ballhausen D, Bonafé L, Terhal P, Unger SL, Bellus G, Classen M, et al. Recessive multiple epiphyseal dysplasia (rMED): phenotype delineation in eighteen homozygotes for DTDST mutation R279W. J Med Genet. 2003; 40:65–71.
Bonafé L, Mittaz-Crettol L, Ballhausen D, Superti-Furga A. Multiple epiphyseal dysplasia, recessive. In: Adam MP, Ardinger HH, Pagon RA, ., editors. GeneReviews. University of Washington; 1993. http://www.ncbi.nlm.nih.gov/books/NBK1306/ . [Accessed 23 August 2019]
Dahlqvist J, Orlén H, Matsson H, Dahl N, Lönnerholm T, Gustavson KH. Multiple epiphyseal dysplasia. Acta Orthop. 2009; 80:711–715.
Miura H, Noguchi Y, Mitsuyasu H, Nagamine R, Urabe K, Matsuda S, Iwamoto Y. Clinical features of multiple epiphyseal dysplasia expressed in the knee. Clin Orthop. 2000; 380:184–190.
Kim SJ, Ramanathan AK, Jeon YS, Song HR. The fate of hips that are conservatively treated in multiple epiphyseal dysplasia. J Pediatr Orthop B. 2017; 26:526–531.
Sponer P, Karpas K, Cenĕk J. [Surgical treatment of multiple epiphyseal dysplasia in the hip joints in childhood–short-term results]. Acta Chir Orthop Traumatol Cech. 2003; 70:243–247.
Li LY, Zhao Q, Ji SJ, Zhang LJ, Li QW. Clinical features and treatment of the hip in multiple epiphyseal dysplasia in childhood. Orthopedics. 2011; 34:352.
Wenger DR, Pring ME, Hosalkar HS, Caltoum CB, Lalonde FD, Bastrom TP. Advanced containment methods for Legg-Calvé-Perthes disease: results of triple pelvic osteotomy. J Pediatr Orthop. 2010; 30:749–757.
Stepanovich M, Upasani VV, Bomar JD, Wenger DR. Advanced containment with triple innominate osteotomy in Legg-Calve-Perthes disease: a viable option even in severe cases. J Pediatr Orthop. 2017; 37:563–569.
Zhou L, Willoughby K, Strobel N, Thomason P, Gallagher C, Harambasic M, et al. Classifying adverse events following lower limb orthopaedic surgery in children with cerebral palsy: reliability of the modified Clavien-Dindo system. J Pediatr Orthop. 2018; 38:e604–e609.
Bayhan IA, Abousamra O, Rogers KJ, Bober MB, Miller F, Mackenzie WG. Valgus hip osteotomy in children with spondyloepiphyseal dysplasia congenita: midterm results. J Pediatr Orthop. 2019; 39:282–288.
Andrzejewski A, Péjin Z, Finidori G, Badina A, Glorion C, Wicart P. Can chiari osteotomy favorably influence long-term hip degradation in multiple epiphyseal dysplasia and pseudoachondroplasia? J Pediatr Orthop. 2021; 41:e135–e140.
Muenzer J, Beck M, Eng CM, Escolar ML, Giugliani R, Guffon NH, et al. Multidisciplinary management of Hunter syndrome. Pediatrics. 2009; 124:e1228–e1239.

Auteurs

Amelia M Lindgren (AM)

Department of Orthopedic Surgery, Rady Children's Hospital, San Diego, San Diego, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH